"

71 PCN Chemotherapy Response and Survival Data

Patients with diagnosis of solid organ cancer who were in good enough health to participate in clinical trial > ambulatory and good functional status)
Cancer Type Response rate % Median Duration of Response (months) Median Survival (Months)
Breast 25-55 8-12 24-36
Lung (Nonsmall Cell): Squamous 24-36 4-6 6-11
Lung (Nonsmall Cell): Nonsquamous 20-25 4-6 10-12 4-6 10-12
Esophagus 30-50 4-6 6-9
Gastro-Esophageal Junction 40-60 6-8 9-12
Gastric: HER2 negative 20-40 4-7 6-11
Gastric: HER2 positive ~50 6-7 12-14
Pancreas 20-32 4-6 8-11
Liver: Hepatocellular HCC 25-50 2-5
Liver: Nonhepatitis C related HCC 6-10
Liver: Hepatitis C related HCC 14
Biliary-Cholangiocarcinoma 20-35 4-8 9-14
Colon 30-45 8-10 16-21
Melanoma 15-40 4-14 6-15

License

Icon for the Creative Commons Attribution-NonCommercial 4.0 International License

Reference Notes for Palliative Care Consultation Copyright © 2018 by Robert F. Johnson MD, MEd is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, except where otherwise noted.

Share This Book